Modulation of elongation factor-1 delta (EF-1δ) expression by oncogenes in human epithelial cells

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 385-392

  Kolettas, Evangelos ^a   Lymboura, Margarita ^a   Khazaie, Khashayarsha ^b   Luqmani, Yunis ^a,c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Elongation factor 1delta (EF 1 ); Epithelial cells; Oncogenes; Transformation; Translation

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; ELONGATION FACTOR 1; ELONGATION FACTOR 1DELTA; INITIATION FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYBRIDIZATION; KERATINOCYTE; MALIGNANT TRANSFORMATION; MESSENGER RNA SYNTHESIS; MODULATION; ONCOGENE; ONCOGENE C ERB; ONCOGENE C FOS; ONCOGENE MYC; ONCOGENE RAS; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

CLONING, MOLECULAR; DEXAMETHASONE; DNA, NEOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; GLUCOCORTICOIDS; HUMANS; ONCOGENE PROTEIN P21(RAS); ONCOGENES; PEPTIDE ELONGATION FACTOR 1; PEPTIDE ELONGATION FACTORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031921947     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Luqmani Y A and Lymboura M: Subtraction hybridisation cloning of RNA amplified from different cell populations microdissected from cryostat tissue sections. Ana Biochem. 221: 102-109, 1994.
2. Sanders JP, Raggiaschi R, Moller W and Morales J: The human leucine zipper containing guanine nucleotide exchange protein elongation factor 1δ. Biochim. Biophys Acta 1174: 87-90, 1993.
3. Sonenberg N: Translation factors as effectors of cell growth and tumourigenesis. Curr Op Cell Biol 5: 955-960,1993.
4. Boukamp P, Petrusevska RT, Breitkreutz J, Hornung A, Markham, A and Fusenig NE: Normal keratinisation in a spontaneously immortalised aneuploid human kerationocyte cell line. J Cell Biol 106: 761-771, 1988.
5. Soule HD, Vazquez J, Long A, Albert S and Brennan M: A human cell line from pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1413, 1973.
6. Mann R, Mulligan, RC and Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33: 153-159, 1983.
7. Miller AD and Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: 2895-2902, 1984.
8. Boulter CA and Wagner EF: A universal retroviral vector for efficient expression of exogenous genes. Nucleic Acids Res 15: 7194, 1987.
9. Boulter CA and Wagner EF: The effects of v-src expression on the differentiation of embryonal carcinoma cells. Oncogene 2: 207-214, 1988.
10. Ullrich, A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J. Yarden, Y, Liberman TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg, PH: Human EGF receptor cDNA and abberant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.) 309: 418-425, 1984.
11. McGeady ML, Kerby S, Shankar V, Ciardiello F, Salomon, D and Seideman, M: Infection with a TGFa retroviral vctor transforms normal mouse mammary epithelial cells but not normal fibroblasts. Oncogene 4: 1375-1382, 1989.
12. ras is concentration-dependent. Oncogene 2: 259-265, 1988.
13. Wagner EF, Vanek M and Vennstrom, B: Transfer of genes into embryonal carcinoma cells by retrovirus infection: Efficient expression from an internal promoter. EMBO J 4: 663-666, 1985.
14. DiFiore PP, Pierce JH, Kraus MH, Segatto O, King, CR and Aaronson SA: erbB-2 is a potent oncogene when overexpressed in NIH3T3 cells. Science 237: 178-182, 1987.
15. Gonos ES, Kolettas E, and Spandidos DA: Immortalisation Methods: Retroviral Genes - ras. I: Cell and Tissue Culture: Laboratory Procedures, (Griffiths, JB, Doyle, A and Newell, DG, eds), John Wiley and Sons Ltd., 1995, Chapter 26, Unit 26. 7.2 part 26H, Module 26H:2.
16. Kolettas E, Gonos ES and Spandidos, DA: Immortalisation Methods: Retroviral Genes - myc. In: Cell and Tissue Culture: Laboratory Procedures (Griffiths, J. B., Doyle, A. and Newell, D. G., eds), John Wiley and Sons Ltd., 1995, Chapter 26, Unit 26. 7.1 part 26H, Module 26H: 1.
17. Hynes NE, Taverna D, Harwerth I, Ciardiello F, Salomon DS, Yamamoto T and Groner B: Epidermal growth factor receptor but not c-erbB-2 activation prevents lactogenic hormone induction of the β-casein gene in normal mammary epithelial cells. Mol Cell Biol 10: 4027-4034, 1990.
18. Auffray C and Rougeon F: Purification of mouse immunoglobulin heavy chain messenger RNAs from total myeloma mouse RNA. Eur J Biochem 107: 303-314, 1980.
19. Morales J, Comier P, Mulner-Lorillon O, Poulhe R and Belle R: Molecular cloning of a new guanine nucleotide exchange protein, EF1 δ. Nucleic Acids Res 20: 4091, 1992.
20. Doppler W, Groner B and Ball RK: Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat-β-casein gene promoter constructs in a mammary epithelial cell line. Proc Natl Acad Sci USA 86: 104-108, 1989.
21. Kaufmann AM, Khazaie K, Wiedemuth M, Rhode-Schulz B, Ullrich A, Schirrmacher V and Lichtner RB: Expression of EGF-receptor correlates with metastatic potential of 13762NF rat mammary adenocarcinoma cells. Int J Oncol 4: 1149-1155, 1994.
22. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, DiFiore PP and Aaronson SA Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189-1194.
23. Grant AG, Flomen RM, Tizard MLV and Grant DAW: Differential screening of a human pancreatic adenocarcinoma lambda gt11 library has identified increased transcription of elongation factor EF-1 alpha in tumour cells. Int J Cancer 51: 740745, 1992.
24. Lew Y, Jones DV, Mars WM, Evans, D, Byrd D and Frazier ML: Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas 7: 144-152, 1992.
25. Sanders, J, Maassen JA and Moller, W: Elongation factor-1 messenger RNA levels in cultured cells were high compared to tissue and are not drastically affected by oncogenic transformation. Nucleic Acids Res 20: 5907-5910, 1992.
26. Cavalius J, Rattan SI and Clark BFC: Change in activity and amount of active EF-1a in ageing and immortal human fibroblast cultures. Exp Gerontol 21:149-157,
27. Derventzi A, Rattan, SI and Clark BFC: Phorbol ester PMA stimulates protein synthesis and increases the levels of active elongation factors EF-1 alpha and EF-2 in ageing human fibroblasts. Mech Ageing Dev 69: 193-205, 1993.
28. Frederickson RM, Montine KS and Sonenberg N: Phosphorylation of eukaryotic translation initiation factor 4E is increased in src-transformed cell lines. Mol Cell Biol 11: 2896-2900, 1991.
29. Rinker-Shaeffer CW, Austin V, Simmer S and Rhoads RE: Rastransformation of cloned rat embryo fibroblasts results in increased rates of protein synthesis and phosphorylation of eukaryotic initiation factor 4E. J Bio Chem 267: 2593-2598, 1992.
30. Frederickson RM, Mushynski WE and Sonenberg N: Phosphorylation of translation initiation factor EIF-4E is induced in a ras-dependent manner during nerve growth factor mediated PC12 cell differentiation. Mol Cell Biol 12: 1239-1247, 1992.
31. Szeberenyi J, Cai H and Cooper G: Effect of dominant inhibitory Haras mutation on neuronal differentiation of PC12 cells. Mol Cell Biol 10: 5324-5332, 1990.
32. Hirakawa T and Ruley HE: Response of cells from ras-oncogene induced growth arrest by a second complementing oncogene. Proc Natl Acad Sci USA 85: 1519-1523, 1988.
33. Ricketts MH and Levinson AD: High level expression of c-Ha-ras fails to fully transform rat-1 cells. Mol Cell Biol 8: 1560-1568, 1988.
34. Ridley AJ, Paterson H, Noble M and Land H: Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7: 1635-1645, 1988.
35. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi S: Cellular committment to oncogene induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839, 1994.
36. Wang H-G, Milla JA, Cox AD, Der JC, Rapp UR, Bock T, Zha H and Reed, JC: R-ras promotes apoptosis caused by growth factor deprivation via a bcl-2 suppressible mechanism. J Cell Biol 129: 1103-1114, 1995.
37. DeBenedetti A and Rhoads RE: Overexpression of eukaryotic protein synthesis initiation factor 4E in Hela cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 87: 8212-8216, 1990.
38. Rosenwald IB, Rhoads DB, Callanan LD, Isselbacher KF and Schmidt EV: Expression of translation initiation factor EIF-4E and E1F-2a in response to growth induction by c-myc. Proc Natl Acad Sci USA 90: 6175-6178, 1993.
39. Lazaris-Karatzas A, Montine KS and Sonenberg N: Malignant transformation by eukaryotic initiation factor subunit that binds to mRNA 5'cap. Nature (Lond.) 345: 544-547, 1990.
40. Lazaris-Karatzas A and Sonenberg N: The mRNA 5' cap-binding protein EIF-4E cooperates with v-myc or E 1A in the transformation of primary rodent fibroblasts. Mol Cell Biol 12: 1234-1238, 1992.
41. Tanigushi S, Miyamoto S, Sadano H and Kobayashi H: Rat elongation factor 1α: Sequence of cDNA from a highly metastatic fos-transfected cell line. Nucleic Acids Res 19: 6949, 1991.
42. Tatsuka M, Mitsui H, Wada M, Nagata A, Nojima H and Okayama H: Elongation factor 1α gene determines susceptibility to transformation. Nature (Lond.) 359: 333-336, 1992.